Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - STOCK-BASED COMPENSATION
Stock-based Compensation RGNX - REGENXBIO Inc.
40.3 M
LAST VALUE
1.86%
2 YEAR CAGR
19.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR